Phosphatidylcholine transfer protein interacts with thioesterase superfamily member 2 to attenuate insulin signaling

Science Signaling

Volumn 6, Issue 286, 2013, Pages

  Ersoy, Baran A ^a   Tarun, Akansha ^a   D'Aquino, Katharine ^b   Hancer, Nancy J ^b   Ukomadu, Chinweike ^a   White, Morris F ^b   Michel, Thomas ^a   Manning, Brendan D ^c   Cohen, David E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 2; LECITHIN TRANSFER PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLCHOLINE; PROTEIN; PROTEIN THEM2; TUBERIN; UNCLASSIFIED DRUG; ACOT13 PROTEIN, HUMAN; ACOT13 PROTEIN, MOUSE; GLUCOSE; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; PHOSPHOLIPID TRANSFER PROTEIN; TARGET OF RAPAMYCIN KINASE; THIOL ESTER HYDROLASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GENE INACTIVATION; GLUCOSE HOMEOSTASIS; HORMONE ACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; CELL STRAIN HEK293; GENETICS; HOMEOSTASIS; IC 50; LIVER; METABOLISM; MOUSE; PHOSPHORYLATION; TRANSGENIC MOUSE; HEK293 CELL LINE; IC50;

MAMMALIA; MUS;

ANIMALS; GLUCOSE; HEK293 CELLS; HOMEOSTASIS; HUMANS; INHIBITORY CONCENTRATION 50; INSULIN; LIVER; MICE; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; THIOLESTER HYDROLASES; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84884237166     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004111     Document Type: Article

References (44)

1. K. W. Wirtz, Phospholipid transfer proteins. Annu. Rev. Biochem. 60, 73-99 (1991).
2. A. P. M. de Brouwer, J. Westerman, A. Kleinnijenhuis, L. E. Bevers, B. Roelofsen, K. W. A. Wirtz, Clofibrate-induced relocation of phosphatidylcholine transfer protein to mitochondria in endothelial cells. Exp. Cell Res. 274, 100-111 (2002).
3. S. L. Roderick, W. W. Chan, D. S. Agate, L. R. Olsen, M. W. Vetting, K. R. Rajashankar, D. E. Cohen, Structure of human phosphatidylcholine transfer protein in complex with its ligand. Nat. Struct. Biol. 9, 507-511 (2002). (Pubitemid 34693804)
4. H. W. Kang, J. Wei, D. E. Cohen, PC-TP/StARD2: Of membranes and metabolism. Trends Endocrinol. Metab. 21, 449-456 (2010).
5. E. F. Scapa, A. Pocai, M. K.Wu, R. Gutierrez-Juarez, L. Glenz, K. Kanno, H. Li, S. Biddinger, L. A. Jelicks, L. Rossetti, D. E. Cohen, Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2. FASEB J. 22, 2579-2590 (2008). (Pubitemid 351948675)
6. E. Y. Shishova, J. M. Stoll, B. A. Ersoy, S. Shrestha, E. F. Scapa, Y. X. Li, M. W. Niepel, Y. Su, L. A. Jelicks, G. L. Stahl, M. A. Glicksman, R. Gutierrez-Juarez, G. D. Cuny, D. E. Cohen, Genetic ablation or chemical inhibition of phosphatidylcholine transfer protein attenuates diet-induced hepatic glucose production. Hepatology 54, 664-674 (2011).
7. H. J. Pan, D. S. Agate, B. L. King, M. K. Wu, S. L. Roderick, E. H. Leiter, D. E. Cohen, A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine transfer protein. FEBS Lett. 580, 5953-5958 (2006). (Pubitemid 44739944)
8. G. Dolley, M. T. Berthier, B. Lamarche, J. P. Després, C. Bouchard, L. Pérusse, M. C. Vohl, Influences of the phosphatidylcholine transfer protein gene variants on the LDL peak particle size. Atherosclerosis 195, 297-302 (2007). (Pubitemid 350087959)
9. K. Kanno, M. K. Wu, D. A. Agate, B. K. Fanelli, N. Wagle, E. F. Scapa, C. Ukomadu, D. E. Cohen, Interacting proteins dictate function of the minimal START domain phosphatidylcholine transfer protein/StarD2. J. Biol. Chem. 282, 30728-30736 (2007). (Pubitemid 350035203)
10. J. Wei, H.W. Kang, D. E. Cohen, Thioesterase superfamily member 2 (Them2)/acyl-CoA thioesterase 13 (Acot13): A homotetrameric hotdog fold thioesterase with selectivity for long-chain fatty acyl-CoAs. Biochem. J. 421, 311-322 (2009).
11. H. W. Kang, K. Kanno, E. F. Scapa, D. E. Cohen, Regulatory role for phosphatidylcholine transfer protein/StarD2 in the metabolic response to peroxisome proliferator activated receptor alpha (PPARa). Biochim. Biophys. Acta 1801, 496-502 (2010).
12. H. W. Kang, M. W. Niepel, S. Han, Y. Kawano, D. E. Cohen, Thioesterase superfamily member 2/acyl-CoA thioesterase 13 (Them2/Acot13) regulates hepatic lipid and glucose metabolism. FASEB J. 26, 2209-2221 (2012).
13. X. J. Sun, P. Rothenberg, C. R. Kahn, J. M. Backer, E. Araki, P. A. Wilden, D. A. Cahill, B. J. Goldstein, M. F. White, Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73-77 (1991). (Pubitemid 21896701)
14. P. T. Bhaskar, N. Hay, The two TORCs and Akt. Dev. Cell 12, 487-502 (2007). (Pubitemid 46523652)
15. D. D. Sarbassov, D. A. Guertin, S. M. Ali, D. M. Sabatini, Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101 (2005). (Pubitemid 40262113)
16. S. Kovacic, C. L. Soltys, A. J. Barr, I. Shiojima, K. Walsh, J. R. Dyck, Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J. Biol. Chem. 278, 39422-39427 (2003). (Pubitemid 37248497)
17. R. Halse, J. J. Rochford, J. G. McCormack, J. R. Vandenheede, B. A. Hemmings, S. J. Yeaman, Control of glycogen synthesis in cultured human muscle cells. J. Biol. Chem. 274, 776-780 (1999).
18. B. D. Manning, A. R. Tee, M. N. Logsdon, J. Blenis, L. C. Cantley, Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 10, 151-162 (2002). (Pubitemid 34876569)
19. A. Garami, F. J. Zwartkruis, T. Nobukuni, M. Joaquin, M. Roccio, H. Stocker, S. C. Kozma, E. Hafen, J. L. Bos, G. Thomas, Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11, 1457-1466 (2003). (Pubitemid 36776533)
20. A. J. Folkes, K. Ahmadi, W. K. Alderton, S. Alix, S. J. Baker, G. Box, I. S. Chuckowree, P. A. Clarke, P. Depledge, S. A. Eccles, L. S. Friedman, A. Hayes, T. C. Hancox, A. Kugendradas, L. Lensun, P. Moore, A. G. Olivero, J. Pang, S. Patel, G. H. Pergl-Wilson, F. I. Raynaud, A. Robson, N. Saghir, L. Salphati, S. Sohal, M. H. Ultsch, M. Valenti, H. J. A. Wallweber, N. C. Wan, C. Wiesmann, P. Workman, A. Zhyvoloup, M. J. Zvelebil, S. J. Shuttleworth, The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl) -4- morphol in-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer. J. Med. Chem. 51, 5522-5532 (2008).
21. M. K. Holz, B. A. Ballif, S. P. Gygi, J. Blenis, mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123, 569-580 (2005). (Pubitemid 41608461)
22. A. R. Saltiel, C. R. Kahn, Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806 (2001). (Pubitemid 34000783)
23. M. F. White, IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283, E413-E422 (2002). (Pubitemid 35230477)
24. V. Stambolic, A. Suzuki, J. L. de la Pompa, G. M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J. M. Penninger, D. P. Siderovski, T. W. Mak, Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39 (1998). (Pubitemid 28458022)
25. X. T. Wang, K. D. McCullough, T. F. Franke, N. J. Holbrook, Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 275, 14624-14631 (2000). (Pubitemid 30339753)
26. S. Boura-Halfon, Y. Zick, Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 296, E581-E591 (2009).
27. K. D. Copps, M. F. White, Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55, 2565-2582 (2012).
28. M. F. White, The insulin signalling system and the IRS proteins. Diabetologia 40, S2-S17 (1997). (Pubitemid 27306917)
29. A. R. Tee, D. C. Fingar, B. D. Manning, D. J. Kwiatkowski, L. C. Cantley, J. Blenis, Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl. Acad. Sci. U.S.A. 99, 13571-13576 (2002). (Pubitemid 35215423)
30. X. S. Gao, Y. Zhang, P. Arrazola, O. Hino, T. Kobayashi, R. S. Yeung, B. G. Ru, D. J. Pan, Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol. 4, 699-704 (2002). (Pubitemid 34993706)
31. D. A. Agate, thesis, Albert Einstein College of Medicine, Bronx, NY (2006).
32. M. K.Wu,M.O.Boylan, D. E. Cohen, Cloning and gene structure of rat phosphatidylcholine transfer protein, Pctp. Gene 235, 111-120 (1999). (Pubitemid 29327288)
33. J. H. Wu, Y. D. Tseng, C. F. Xu, T. A. Neubert, M. F. White, S. R. Hubbard, Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2. Nat. Struct. Mol. Biol. 15, 251-258 (2008). (Pubitemid 351654043)
34. E. Alvarez, I. C. Northwood, F. A. Gonzalez, D. A. Latour, A. Seth, C. Abate, T. Curran, R. J. Davis, Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J. Biol. Chem. 266, 15277-15285 (1991). (Pubitemid 21907645)
35. T. Ide, H. Shimano, N. Yahagi, T. Matsuzaka, M. Nakakuki, T. Yamamoto, Y. Nakagawa, A. Takahashi, H. Suzuki, H. Sone, H. Toyoshima, A. Fukamizu, N. Yamada, SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat. Cell Biol. 6, 351-357 (2004). (Pubitemid 38584825)
36. J. Huang, B. D. Manning, The TSC1-TSC2 complex: A molecular switchboard controlling cell growth. Biochem. J. 412, 179-190 (2008). (Pubitemid 351758225)
37. D. J. Kwiatkowski, B. D. Manning, Tuberous sclerosis: A GAP at the crossroads of multiple signaling pathways. Hum. Mol. Genet. 14, R251-R258 (2005). (Pubitemid 41631882)
38. G. Benvenuto, S. W. Li, S. J. Brown, R. Braverman,W. C. Vass, J. P. Cheadle, D. J. J. Halley, J. R. Sampson, R. Wienecke, J. E. DeClue, The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene 19, 6306-6316 (2000). (Pubitemid 32641844)
39. C. C. Dibble, J. M. Asara, B. D. Manning, Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol. Cell. Biol. 29, 5657-5670 (2009).
40. M. K. Wu, H. Hyogo, S. Yadav, P. M. Novikoff, D. E. Cohen, Impaired response of biliary lipid secretion to a lithogenic diet in phosphatidylcholine transfer protein-deficient mice. J. Lipid Res. 46, 422-431 (2005). (Pubitemid 43109777)
41. X. C. Dong, K. D. Copps, S. D. Guo, Y. D. Li, R. Kollipara, R. A. DePinho, M. F. White, Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab. 8, 65-76 (2008). (Pubitemid 351863393)
42. L. Feng, W. W. Chan, S. L. Roderick, D. E. Cohen, High-level expression and mutagenesis of recombinant human phosphatidylcholine transfer protein using a synthetic gene: Evidence for a C-terminal membrane binding domain. Biochemistry 39, 15399-15409 (2000). (Pubitemid 32002766)
43. K. Kanno, M. K. Wu, E. F. Scapa, S. L. Roderick, D. E. Cohen, Structure and function of phosphatidylcholine transfer protein (PC-TP)/StarD2. Biochim. Biophys. Acta 1771, 654-662 (2007). (Pubitemid 46856894)
44. D. H. Kim, D. D. Sarbassov, S. M. Ali, J. E. King, R. R. Latek, H. Erdjument-Bromage, P. Tempst, D. M. Sabatini, mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (2002). (Pubitemid 34876545)